Clinical Trial Update: A Study of Docetaxel and Lobaplatin Versus Docetaxel and Carboplatin Combination Regimen in Patients With Platinum-sensitive (>6 Months) Relapsed Ovarian Cancer

View source ↗

Summary

Clinical trial update comparing docetaxel plus lobaplatin versus docetaxel plus carboplatin in platinum-sensitive relapsed ovarian cancer, with status not provi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)
• Lobaplatin (lobaplatin)

Snippet

Sponsor: Wuhan University | Conditions: Recurrent Ovarian Cancer | Status: UNKNOWN